A/PROF Matt Field ~ Associate Professor, Bioinformatics
Molecular and Cell Biology
- About
-
- Teaching
- Interests
-
- Research
-
- Bioinformatics
- Personalised Medicine
- Immunogenomics
- Disease Causing Variants
- Experience
-
- 2020 to present - Associate Professor, James Cook University (Cairns, Australia)
- 2020 to present - Analysis Lead, Garvan Institue of Medical Research (Sydney, Australia)
- 2018 to present - Co-director, Centre for Tropical Bioinformatics and Molecular Biology (Cairns, Australia)
- 2010 to 2020 - Senior Bioinformatics Manager, Australian National University (Canberra, Australia)
- 2016 to 2019 - Senior Bioinformatics Fellow, James Cook University (Cairns, Australia)
- 2010 - Bioinformatics Software Development Team Leader, Biomatters (Auckland, New Zealand)
- 2004 to 2010 - Assistant Bioinformatics Coordinator, Genome Sciences Centre (Vancouver, Canada)
- Research Disciplines
- Socio-Economic Objectives
Matt Field is an Associate Professor in Bioinformatics at James Cook University. He currently holds an NHMRC Emerging Leader II Fellowship and was recently awarded the Frank Fenner Early Career Fellowship for the highest scoring ECR applicant. A/Prof Field is a founder and co-director of the Centre for Tropical Bioinformatics and Molecular Biology and specialises in developing high-throughput bioinformatic analysis pipelines.
In the last five years Dr Field has published 50 peer reviewed publications in high impact journals such as Nature (x3), Cell, Science Advances (x2) and PNAS (x2), which have been cited over 5000 times. To date he has been a named investigator on $6 million in grants with >$2.5 million as sole CI. He is a Chief Investigator for the Centre for Personalised Immunology, an NHMRC Centre of Research Excellence focused on bringing genomics and personalized medicine into routine clinical practice. He is also an associate editor for Human Genomics (Springer/Nature).
From 2010 to 2015 Dr Field worked as Senior Bioinformatics Manager at the Australian National University, developing software to uncover the underlying genetic cause of human diseases such as lupus, diabetes, and melanoma. During this time he developed a high-throughput variant detection pipeline which has analysed over 4000 exomes and 3000 genomes to date. He completed a PhD at ANU in medical science titled "Computational Analysis of Genetic Variation" with supervisor Chris Goodnow.
From 2004 to 2010 Dr Field worked as Assistant Bioinformatic Coordinator at the Genome Sciences Centre in Canada leading a group of bioinformaticians in a high-throughput research environment studying a variety of cancers. Prior to this, he completed two Bachelor of Science degrees in computer science and biology from the University of British Columbia.
- Honours
-
- Awards
-
- 2022 - Dean's Award - Highest Research Productivity
- 2020 - ECR Merit Allocation at National Computational Infrastructure
- 2018 - James Cook University Rising Star
- 2017 - Frank Fenner Early Career Fellowship
- Fellowships
-
- 2022 to 2026 - NHMRC Emerging Leader II
- 2018 to 2021 - NHMRC CJ Martin
- Memberships
-
- 2021 - Australian Health Research Alliance (TAAHC)
- 2019 - Executive member Australian Bioinformatics And Computational Biology Society
- 2018 - Chair Bioinformatics Advisory Board QCIF
- 2018 - American Society for Human Genetics
- 2015 - International Society for Computational Biology
- Publications
-
These are the most recent publications associated with this author. To see a detailed profile of all publications stored at JCU, visit ResearchOnline@JCU. Hover over Altmetrics badges to see social impact.
- Journal Articles
-
- Brown G, Cañete P, Wang H, Medhavy A, Bones J, Roco J, He Y, Qin Y, Cappello J, Ellyard J, Bassett K, Shen Q, Burgio G, Zhang Y, Turnbull C, Meng X, Wu P, Cho E, Miosge L, Andrews T, Field M, Tvorogov D, Lopez A, Babon J, López C, Gónzalez-Murillo Á, Garulo D, Pascual V, Levy T, Mallack E, Calame D, Lotze T, Lupski J, Ding H, Ullah T, Walters G, Koina M, Cook M, Shen N, de Lucas Collantes C, Corry B, Gantier M, Athanasopoulos V and Vinuesa C (2022) TLR7 gain-of-function genetic variation causes human lupus. Nature, 605. pp. 349-356
- Chuah A, Li S, Do A, Field M and Andrews D (2022) StabilitySort: assessment of protein stability changes on a genome-wide scale to prioritize potentially pathogenic genetic variation. Bioinformatics, 38 (17). pp. 4220-4222
- Cobos C, Bansal P, Wilson D, Jones L, Zhao G, Field M, Eichenberger R, Pickering D, Ryan R, Ratnatunga C, Miles J, Ruscher R, Giacomin P, Navarro S, Loukas A and Daly N (2022) Peptides derived from hookworm anti-inflammatory proteins suppress inducible colitis in mice and inflammatory cytokine production by human cells. Frontiers in Medicine, 9.
- Field M (2022) Bioinformatic Challenges Detecting Genetic Variation in Precision Medicine Programs. Frontiers in Medicine, 9.
- Field M, Yadav S, Dudchenko O, Esvaran M, Rosen B, Skvortsova K, Edwards R, Keilwagen J, Cochran B, Manandhar B, Bustamante S, Rasmussen J, Melvin R, Chernoff B, Omer A, Colaric Z, Chan E, Minoche A, Smith T, Gilbert M, Bogdanovic O, Zammit R, Thomas T, Aiden E and Ballard J (2022) The Australian dingo is an early offshoot of modern breed dogs. Science Advances, 8 (16).
- Khudhair Z, Alhallaf R, Eichenberger R, Field M, Krause L, Sotíllo J and Loukas A (2022) Administration of Hookworm Excretory/Secretory Proteins Improves Glucose Tolerance in a Mouse Model of Type 2 Diabetes. Biomolecules, 12 (5).
- Mekonnen G, Tedla B, Pearson M, Becker L, Field M, Amoah A, van Dam G, Corstjens P, Mduluza T, Mutapi F, Loukas A and Sotillo J (2022) Characterisation of tetraspanins from Schistosoma haematobium and evaluation of their potential as novel diagnostic markers. PLoS Neglected Tropical Diseases, 16 (1).
- Phie J, Thanigaimani S, Huynh P, Anbalagan R, Moran C, Kinobe R, Moxon J, Field M, Krishna S and Golledge J (2022) Colchicine Does Not Reduce Abdominal Aortic Aneurysm Growth in a Mouse Model. Cardiovascular Therapeutics, 2022.
- Ratnatunga C, Tungatt K, Proietti C, Halstrom S, Holt M, Lutzky V, Price P, Doolan D, Bell S, Field M, Kupz A, Thomson R and Miles J (2022) Characterizing and correcting immune dysfunction in non-tuberculous mycobacterial disease. Frontiers in Immunology, 13.
- Ryan S, Ruscher R, Johnston W, Pickering D, Kennedy M, Smith B, Jones L, Buitrago G, Field M, Esterman A, McHugh C, Browne D, Cooper M, Ryan R, Doolan D, Engwerda C, Miles K, Mitreva M, Croese J, Rahman T, Alexandrov K, Giacomin P and Loukas A (2022) Novel antiinflammatory biologics shaped by parasite–host coevolution. Proceedings of the National Academy of Sciences of the United States of America, 119 (36).
- Schmidt C, Cooke I, Wilson D, Miller D, Peigneur S, Tytgat J, Field M, Takjoo R, Smout M, Loukas A and Daly N (2022) Newly Discovered Peptides from the Coral Heliofungia actiniformis Show Structural and Functional Diversity. Journal of Natural Products, 85 (7). pp. 1789-1798
- Swan T, Russell T, Staunton K, Field M, Ritchie S and Burkot T (2022) A literature review of dispersal pathways of Aedes albopictus across different spatial scales: implications for vector surveillance. Parasites & Vectors, 15 (1).
- Current Funding
-
Current and recent Research Funding to JCU is shown by funding source and project.
Commonwealth Department of Health - Medical Research Future Fund - Cardiovascular Health Mission
Improving clinical pathways for abdominal aortic aneurysm through incorporating biomarkers
- Indicative Funding
- $1,000,000 over 3 years
- Summary
- 20 million people worldwide have weakening of their main abdominal artery (abdominal aortic aneurysm; AAA) and are at high risk of both major adverse cardiovascular events (MACE) and AAA related events (AAA repair and rupture-related death). Most AAAs are identified at a small size when their risk of rupture is low. Management of small AAA focuses on repeat aortic imaging every 6 months to identify when the threshold diameter (50mm in women and 55mm in men) is reached for elective surgical AAA repair. Most small AAAs continue to grow in size and eventually undergo repair. No drugs have been shown to limit AAA growth and the clinical pathway focuses on identifying those needing surgery rather than medical management. There are no established means to individualise care. Our interviews with patients and health professionals indicate that the number one deficiency in current AAA management is the lack of individualising medical management to reduce the high incidence of MACE and AAA related events. Our international AAA alliance is uniquely placed due to our resources (biobank-registry) and IP (bioinformatics, clinical, engineering software, genomics, biomarkers, machine learning and pathogenesis) to addresses this unmet clinical need.
- Investigators
- Jon Golledge, Clare Arnott, Thomas Gasser, Rebecca Evans, Joseph Moxon, Matt Field, Jenna Pinchbeck, Aaron Drovandi, Dylan Morris, Svetha Venkatesh, Truyen Tran, Catherine Rush, Aletta Schutte, Robyn Clay-Williams and Geoffrey Jones (College of Medicine & Dentistry, The George Institute for Global Health, KTH Royal Institute of Technology, College of Public Health, Medical & Vet Sciences, Townsville Hospital and Health Services, Deakin University, The University of New South Wales, Macquarie University and University of Otago)
- Keywords
- Prevention; Complications; Peripheral artery disease; Risk Factors
National Health & Medical Research Council - Investigator Grants
Developing Bioinformatics Capability to Diagnose Infectious Diseases using Clinical Metagenomics
- Indicative Funding
- $1,420,531 over 5 years
- Summary
- Current pathogen identification techniques are limited in terms of their speed, accuracy and inability to detect exotic pathogens. Using an unbiased metagenomic sequencing approach offers an improvement over current practice however supporting bioinformatics workflows are needed to support clinical implementation. This work can have enormous global reach with half the world?s population living in the tropics by 2050, many with limited healthcare options.
- Investigators
- Matt Field (Australian Institute of Tropical Health & Medicine)
- Keywords
- Clinical Metagenomics; Infectious Diseases
Townsville Hospital and Health Service - SERTA Research Capacity Grant
Improving outcomes for patients with muscle wasting disease and liver cancer - SERTA Capacity Research Grant.
- Indicative Funding
- $140,000 over 2 years
- Summary
- The funding of a Research Assistant and the performance of work by the Research Assistant in connection with a program of work undertaken by the Cancer and Metabolism Group within the College of Public Health, Medicine and Veterinary Science aimed at improving outcomes for patients with muscle wasting disease and liver cancer.
- Investigators
- Pankaj Saxena, Lionel Hebbard, Jaishankar Raman, Rozemary Karamatic, Matan Ben David, Craig McFarlane, Ulf Schmitz, Matt Field and Miriam Wankell in collaboration with Shaurya Jhamb, Eun Jin Sun, Zaeem Ahmed, Rhys Gillman and Ryley Dorney (Townsville Hospital and Health Services, College of Public Health, Medical & Vet Sciences and College of Medicine & Dentistry)
- Keywords
- Sarcopenia; Hepatocellular Carcinoma; Liver Cancer
Tour de Cure - PhD Scholarship
Precision Hepatocellular Carcinoma Treatment Using Synthetic Lethality
- Indicative Funding
- $10,000 over 1 year
- Summary
- Hepatocellular carcinoma (HCC) is a major cause of cancer-related mortality. Current therapies for HCC show little efficacy due to extensive heterogeneity in the disease and a lack of corresponding patient-tailored treatment options. The purpose of this project is to validate various bioinformatic approaches to identifying personalised cancer driver genes and methods of targeting them through synthetic lethality. An integrated pipeline will be developed for the simple identification of therapeutics from sequencing of tissue biopsies. Finally, patient-derived organoids matched with patient-specific sequencing information will be used to validate this pipeline, building an important foundation for the future of personalised treatment.
- Investigators
- Rhys Gillman, Lionel Hebbard, Matt Field and Ulf Schmitz (College of Public Health and Medical & Vet Sciences)
- Keywords
- Liver Cancer; Genetics; Synthetic Lethality; Bioinformatics; Precision Medicine
Tropical Australian Academic Health Centre Limited - Research Seed Grants
Using portable long-read sequencing to diagnose Chronic Kidney Disease in regional North QLD Using portable long-read sequencing to diagnose Chronic Kidney Disease in regional North Using portable long-read sequencing to diagnose Chronic Kidney Disease
- Indicative Funding
- $50,000 over 2 years
- Summary
- This project addresses the early diagnosis of genetic predispositions for Chronic Kidney Disease (CKD), which poses an increasing burden on the North Queensland population and unequally affects the Indigenous Australian peoples. We will develop a mobile diagnostic pipeline that allows a rapid and cost-efficient screening for genetic CKD predispositions and circulating biomarkers using a targeted, DNA/RNA long-read sequencing approach.
- Investigators
- Ulf Schmitz, Andrew Mallett, Matt Field, Paul Horwood, Helen Wright, Chirag Patel, Ira Cooke and Ben Lundie (College of Public Health, Medical & Vet Sciences, College of Medicine & Dentistry, College of Healthcare Sciences, Queensland Clinical Genetics Service and Pathology Queensland)
- Keywords
- long-read sequencing; Nanopore; Chronic Kidney Disease; Genetic Testing; targeted sequencing; transcriptomic complexity
Tropical Australian Academic Health Centre Limited - Research Seed Grants
Precision medicine for North Queensland Liver Cancer Patients
- Indicative Funding
- $50,000 over 2 years
- Summary
- Hepatocellular carcinoma (HCC) is an aggressive and poorly treated liver cancer that is rapidly increasing in incidence in North Queensland. Most patients are ineligible to have their cancer surgically removed, and new systemic therapeutics only extend patient lives by six to eigth months. Thus, new treatment approaches are urgently required. Through the collaboration of surgeons, scientists and bioinformaticians we are developing Precision Medicine for North Queensland Liver Cancer Patients. Using bioinformatics and three dimensional culture models we will trial novel therapeutic approaches. This research will rapidly lead to new therapeutic approaches to treat HCC.
- Investigators
- Lionel Hebbard, Pranavan Palamuthusingam, Craig McFarlane and Matt Field (College of Public Health, Medical & Vet Sciences, Townsville Hospital and Health Services and Australian Institute of Tropical Health & Medicine)
- Keywords
- Cancer; Cancer Stem Cell; Organoids
Tropical Australian Academic Health Centre Limited - Microfunding Scheme
Bayesian disease mapping to identify the high-risk population within North Queensland and interventional program for oral cancer prevention.
- Indicative Funding
- $19,500 over 2 years
- Summary
- Oral cancer 5-year survival rates have remained less than 50% for several decades, despite significant improvements in treatment. This is primarily due to patients generally presenting late with advanced stages of the disease. Consequently, in many cases, oral cancer is incurable or requires extensive life-changing surgery and chemo-radiotherapy. Early diagnosis through targeted screening of high-risk population groups would result in more favourable survival rates and treatment outcomes. The aim of this project is to identify specific, local populations in Northern Queensland at increased risk of developing oral cancer with a view to developing a target screening program for oral cancers.
- Investigators
- Peter Thomson, Dileep Sharma, Matt Field, Poornima Ramamurthy and Yousef Abdalla (College of Medicine & Dentistry, College of Public Health, Medical & Vet Sciences and Cairns & Hinterland Hospital & Health Service)
- Keywords
- Bayesian Disease Mapping; Oncology
Tropical Australian Academic Health Centre Limited - Contract Research
Can portable genome sequencing provide a rapid, comprehensive, point-of-care diagnostic test for Far North Queensland hospitals and healthcare centres?
- Indicative Funding
- $49,987 over 2 years
- Summary
- Respiratory disease, fevers, and sepsis are common in FNQ and treatment often requires admission to hospital. These infections have many different causes, and diagnosing them requires multiple tests that take weeks to perform. Consequently, patients are treated with broad-spectrum antibiotics before a pathogen is identified, leading to poorer outcomes for the patient and contributing to the spread of antibiotic-resistant infections. We will trial new genome sequencing technology as a point-of-care diagnostic test for fever, sepsis, and pneumonia at Cairns Hospital, and test the hypothesis that this approach will increase the proportion of infections that are diagnosed and reduce the time-to-diagnosis.
- Investigators
- John McBride, Cadhla Firth, Simon Smith, Joshua Hanson, Matt Field, Emma McBryde, John Miles, Damon Eisen and Chris Heather (College of Medicine & Dentistry, Australian Institute of Tropical Health & Medicine and Queensland Health)
- Keywords
- Genomics; Healthcare; pathogens
National Health & Medical Research Council - Development Grant
Hookworm peptide therapeutic for oral treatment of IBD
- Indicative Funding
- $732,700 over 2 years
- Summary
- We intend to develop an orally delivered peptide that can modulate the immune system and be developed as a therapeutic for inflammatory bowel disease. We have identified a peptide, derived from a hookworm protein, that alleviates the clinical symptoms of experimental colitis when orally administered to mice. The peptide has bioactivity with human cells ex vivo and displays desirable drug-like properties. The aim of this project is to acquire further data on the mechanism of action and formulation conditions to facilitate formal product development prior to licensing and clinical trials.
- Investigators
- Alex Loukas, Norelle Daly, Paul Giacomin, John Miles, Roland Ruscher, Keith Dredge, Istvan Toth, Mariusz Skwarczynski, Matthew Moyle, Ashley Waardenberg, John Croese, Matt Field and Tony Rahman (Australian Institute of Tropical Health & Medicine, The University of Queensland and The Prince Charles Hospital)
- Keywords
- Inflammatory Bowel Disease; Peptide; therapeutic; Hookworm; Oral delivery
National Health & Medical Research Council - Early Career Fellowship - Australian Public Health and Health Services Fellowship
Developing Core Bioinformatics Capacity at the Australian Institute of Tropical Health and Medicine
- Indicative Funding
- $327,193 over 4 years
- Summary
- Cost effective next generation sequencing is now a reality, meaning the bottleneck for research projects has shifted from data generation to data analysis. Researchers at the Australian Institute of Health and Tropical Medicine (AITHM) are engaged in an increasing number of high-impact research projects that require timely access to high-throughput bioinformatics best-practices methodologies. This proposal outlines strategies to develop support for projects requiring bioinformatics within AITHM.
- Investigators
- Matt Field (Australian Institute of Tropical Health & Medicine)
- Keywords
- Bioinformatics; Genomics; Computational Biology
Menzies School of Health Research - 2019/2020 Hot North Pilot and Translation Projects
Portable genome sequencing as a point-of-care diagnostic test in remote tropical Australia.
- Indicative Funding
- $36,159 over 1 year
- Summary
- Respiratory disease, fevers, and sepsis are common in tropical northern Australia, and treatment often requires admission to hospital. We will trial new portable genome sequencing technology as a point-of-care diagnostic test for fever, sepsis, and pneumonia at Thursday Island Hospital in Far North Queensland. We will test the hypothesis that this new approach will increase the proportion of infections that are diagnosed and reduce the time it takes to achieve a diagnosis. Throughout the course of this project, clinical staff and health workers will have the opportunity to be trained in specimen preparation, genome sequencing, and data interpretation.
- Investigators
- Cadhla Firth, John McBride, Joshua Hanson, Matt Field and Anthony Brown in collaboration with Simon Smith (Australian Institute of Tropical Health & Medicine, College of Medicine & Dentistry, Cairns & Hinterland Hospital & Health Service and Torres & Cape Hospital & Health Service)
- Keywords
- Infectious Diseases; Diagnostics; Respiratory Health
- Supervision
-
Advisory Accreditation: I can be on your Advisory Panel as a Primary or Secondary Advisor.
These Higher Degree Research projects are either current or by students who have completed their studies within the past 5 years at JCU. Linked titles show theses available within ResearchOnline@JCU.
- Current
-
- Targeting DNA Repair in HCC through Synthetic Lethality (PhD , Secondary Advisor)
- Unravelling genomic patterns of population structure and fitness in the Australian koala (Phascolarctos cinereus) (PhD , Secondary Advisor)
- Completed
-
- High-throughput and high-definition analysis of human T cell repertoires in health and disease (2020, PhD , Secondary Advisor)
- Molecular profiling of immunity to infectious disease using human challenge models (2020, PhD , Secondary Advisor)
- Investigating the immunomodulatory properties of the hookworm recombinant secretome (2019, PhD , Secondary Advisor)
- Ecology and population genomics of Aedes Albopictus in the Torres Strait, Australia (2022, PhD , Secondary Advisor)
- Experimental Hookworm Infection in Humans with Metabolic Disease (2022, PhD , Secondary Advisor)
- Collaboration
-
The map shows research collaborations by institution from the past 7 years.
Note: Map points are indicative of the countries or states that institutions are associated with.- 5+ collaborations
- 4 collaborations
- 3 collaborations
- 2 collaborations
- 1 collaboration
- Indicates the Tropics (Torrid Zone)
Connect with me
- Phone
- Location
-
- E4.110, Queensland Tropical Health Alliance (Cairns campus)
- Advisory Accreditation
- Primary Advisor
- Find me on…
-
My research areas
Similar to me
-
Dr Gregory MaesCollege of Science & Engineering
-
Dr Martha CooperAustralian Institute of Tropical Health & Medicine
-
Dr Javier Sotillo-GallegoAustralian Institute of Tropical Health & Medicine